104 related articles for article (PubMed ID: 6425418)
1. [Interdependence between hormonal disorders, staging and degree of malignancy of prostatic gland cancer. 2].
Szymanowski J; Baranowska B; Rozbicka G; Jeske W; Zgliczynski S
J Urol (Paris); 1983; 89(9):663-8. PubMed ID: 6425418
[TBL] [Abstract][Full Text] [Related]
2. [Interdependence between hormonal disorders, stage of development and degree of malignancy of prostatic cancer. 1].
Szymanowski J; Baranowska B; Niewiadomska A; Wysocki M; Kobuszewska-Faryna M; Zgliczynski S
J Urol (Paris); 1983; 89(8):597-600. PubMed ID: 6677708
[TBL] [Abstract][Full Text] [Related]
3. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
4. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219
[TBL] [Abstract][Full Text] [Related]
5. Changes in gonadotrophin and ovarian hormone levels during the estrous cycle of black-tailed deer (Odocoileus hemionus columbianus).
McKeown BA; Sadleir RM
Biochem Exp Biol; 1978; 14(3):215-20. PubMed ID: 571734
[TBL] [Abstract][Full Text] [Related]
6. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
7. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
[TBL] [Abstract][Full Text] [Related]
8. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
[TBL] [Abstract][Full Text] [Related]
10. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
Zgliczynski S; Baranowska B; Szymanowski J
J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
[TBL] [Abstract][Full Text] [Related]
11. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract][Full Text] [Related]
12. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
[TBL] [Abstract][Full Text] [Related]
13. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy.
Lind T; Cameron EH; Hunter WM
Br J Obstet Gynaecol; 1978 Feb; 85(2):138-41. PubMed ID: 626723
[TBL] [Abstract][Full Text] [Related]
14. Effect of estrogens and progesterone on gonadotropin and prolactin release in a patient with androgen insensitivity.
Nicoletti I; Filipponi P; Fedeli L; Santori PA; Santeusanio F
Obstet Gynecol; 1981 Oct; 58(4):527-32. PubMed ID: 6792578
[TBL] [Abstract][Full Text] [Related]
15. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
16. Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release.
March CM; Marrs RP; Goebelsmann U; Mishell DR
Obstet Gynecol; 1981 Jul; 58(1):10-6. PubMed ID: 6787487
[TBL] [Abstract][Full Text] [Related]
17. The basal levels of serum prolactin (PRL), luteinizine hormone (LH), follicle stimulating hormone (FSH), testosterone, thyroxine (T4), and cortisol in patients with pituitary mass: detection and evaluation.
Namking M; Pavasuthipaisit K; Lerthamtewe W; Bunyaratavej S; Himathongkam T
J Med Assoc Thai; 1981 Feb; 64(2):76-85. PubMed ID: 6785372
[No Abstract] [Full Text] [Related]
18. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
Hsing AW; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
[TBL] [Abstract][Full Text] [Related]
19. Endocrine patterns associated with puberty in male and female cattle.
Schams D; Schallenberger E; Gombe S; Karg H
J Reprod Fertil Suppl; 1981; 30():103-10. PubMed ID: 6820050
[TBL] [Abstract][Full Text] [Related]
20. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels.
Huhtaniemi I; Nikula H; Rannikko S
J Androl; 1987; 8(6):355-62. PubMed ID: 3123445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
